Today, a Director at Danaher Corp (DHR), Donald Ehrlich, sold shares of DHR for $664.7K.
Following Donald Ehrlich’s last DHR Sell transaction on October 25, 2018, the stock climbed by 33.1%. In addition to Donald Ehrlich, 6 other DHR executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Danaher Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $4.88 billion and quarterly net profit of $334 million. In comparison, last year the company earned revenue of $4.7 billion and had a net profit of $567 million. DHR’s market cap is $93.84B and the company has a P/E ratio of 38.72. Currently, Danaher Corp has an average volume of 2.55M.
Based on 9 analyst ratings, the analyst consensus is Strong Buy with an average price target of $136.89, reflecting a 5.0% upside.
In the last 30 days, insiders have sold $34.82M worth of DHR shares and purchased $393.4K worth of DHR shares. The insider sentiment on Danaher Corp has been negative according to 77 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Donald Ehrlich’s trades have generated a -9.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
